We suggest that CBD, through its direct effect on inhibiting the NF-κB pathway, may indirectly contribute to inhibiting the activation of HSCs and thus prevent liver fibrosis, the next stage of CH. Here, NFKB1 is linked to Hepatic fibrosis.